Effect of gamma-hydroxybutyrate on pain, fatigue, and the alpha sleep anomaly in patients with fibromyalgia. Preliminary report

Journal of Rheumatology

Volumn 25, Issue 10, 1998, Pages 1986-1990

  Scharf, Martin B ^a,b   Hauck, Mabel ^a   Stover, Robin ^a   Mcdannold, Michael ^a   Berkowitz, David ^a  

^a CRSD ^*

^b Tri State Sleep Disorders Center   (United States)

Author keywords

Fibromyalgia; Gamma hydroxybutyrate; Sleep

Indexed keywords

4 HYDROXYBUTYRIC ACID;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FATIGUE; FIBROMYALGIA; HUMAN; NARCOLEPSY; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; POLYSOMNOGRAPHY; PRIORITY JOURNAL; SLEEP STAGE; SLOW WAVE SLEEP;

ADULT; FATIGUE; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PAIN; PILOT PROJECTS; POLYSOMNOGRAPHY; SLEEP DISORDERS; SODIUM OXYBATE;

EID: 0031752568     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-72.
2. Wolfe F, Cathey MA. Prevalence of primary and secondary fibrositis. J Rheumatol 1982;10:965-8.
3. Moldofsky H. Sleep and musculoskeletal pain. Am J Med 1986;81 Suppl:85-9.
4. Moldofsky H. Sleep and fibrositis syndrome. Rheum Dis Clin North Am 1989;15:91-103.
5. Moldofsky H. The contribution of sleep-wake physiology to fibromyalgia. In: Fricton JR, Awab E, editors. Advances in pain research and therapy. Vol 17. New York: Rover Press; 1990:227-40.
6. Mamelak M. Gamma hydroxybutyrate: an endogenous regulator of eneray metabolism. Neurosci Biobehav Rev 1989;13:197-8.
7. Mamelak M, Escriu JM, Stokan O. The effects of gammahydroxybutyrate on sleep. Biol Psychiatr 1977;12:273-88.
8. Lapierre O, Montplaisir J, Lamarre M, Bedard MA. The effects of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further consideration on REM-sleep triggering mechanisms. Sleep 1990;13:24-30.
9. Series F, Series I, Cormier Y. Effects of enhancing slow-wave sleep by gamma-hydroxybutyrate on obstructive sleep apnea. Am Rev Respir Dis 1992;145:1378-83.
10. Mamelak M, Scharf MB, Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 1986;9:285-9.
11. Scharf MB, Brown D, Woods M, Brown L, Hirschowitz J. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatry 1985;46:222-5.
12. Van Cauter E, Plat L, Scharf MB, et al. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gamma-hydroxybutyrate in normal young men. J Clin Investigation 1997;100:745-53.
13. Sassin JF, Parher DC, Mace JW, Gotting RW, Johnson LC, Rossman LG. Human growth hormone release: relation to slow wave sleep and sleep waking cycles. Science 1969;165:513-5.
14. Broughton R, Mamelak M. Effects of nocturnal gammahydroxybutyrate on sleep waking patterns in narcolepsycataplexy. Can J Neurol Sci 1980;7:23-31.
15. Scharf MB, Brown D, Woods M, Brown L, Hirschowitz J. The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy. J Clin Psychiatr 1985;46:222-5.
16. Scrima L, Hartman PG, Johnson FH Jr, Thomas E, Hiller FC. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study. Sleep 1990;13:479-90.
17. Scharf M, Fletcher K, Jennings S. Current pharmacologic management of narcolepsy. Am Family Physician 1988; July: 143-8.
18. Rechtschaffen A, Kales A, editors. A manual of standardized terminology: techniques and scoring system for sleep stages of human subjects. Public Health Service Publications No. 204. Washington: U.S. Government Printing Office; 1968.
19. Scharf MB, Lai AA, Branigan B, Stover R, Berkowitz DB. Pharmacokinetic effects of gammahydroxybutyrate (GHB) in narcoleptic patients. Sleep 1998;21:507-14.
20. Palatine P, Tedischi L, Frison G, et al. Dose dependent absorption and elimination of gamma-hydroxybutyrate in healthy volunteers. Eur J Clin Pharmacol 1993;45:353-6.
21. Kales A, Scharf MB, Kales JD, Soldatos CR. Rebound insomnia: a potential hazard following discontinuation of certain benzodiazepines. JAMA 1979;241:1692-5.